Cumberland Pharmaceuticals (CPIX) Profit After Tax (QoQ) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 101.27 Mn | 90.27 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.26% |
| Dec 31, 2025 | 26.70% |
| Sep 30, 2025 | -163.12% |
| Jun 30, 2025 | -158.93% |
| Mar 31, 2025 | 166.10% |
| Dec 31, 2024 | -23.73% |
| Sep 30, 2024 | -41.58% |
| Jun 30, 2024 | 42.94% |
| Mar 31, 2024 | 69.81% |
| Dec 31, 2023 | -500.59% |
| Sep 30, 2023 | -220.30% |
| Jun 30, 2023 | 406.25% |
| Mar 31, 2023 | 107.06% |
| Dec 31, 2022 | -476.70% |
| Sep 30, 2022 | 68.99% |
| Jun 30, 2022 | 2.69% |
| Mar 31, 2022 | 63.55% |
| Dec 31, 2021 | -264.61% |
| Sep 30, 2021 | -245.62% |
| Jun 30, 2021 | 306.61% |